Cigna Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cigna Corp (CI)
Cigna Corp stock price live, this page displays NYSE CI stock exchange data. View the CI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cigna Corp real time stock price chart below.
What Is the Cigna Corp Stock Price Today?
The Cigna Corp stock price today is 280.97.
What Is the Stock Symbol for Cigna Corp?
The stock symbol for Cigna Corp is "CI."
What Stock Exchange Does Cigna Corp Trade On?
Cigna Corp is listed and trades on the NYSE stock exchange.
Is Cigna Corp a Good Stock to Buy?
Determining whether Cigna Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CI quote. (ISIN: US1255231003) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the Cigna Corp Stock Price Today?
The Cigna Corp stock price today is 280.97.
What Is the Stock Symbol for Cigna Corp?
The stock symbol for Cigna Corp is "CI."
What Stock Exchange Does Cigna Corp Trade On?
Cigna Corp is listed and trades on the NYSE stock exchange.
Is Cigna Corp a Good Stock to Buy?
Determining whether Cigna Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CI quote. (ISIN: US1255231003) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Fair Value
An estimate of a Cigna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
279.67
284.24
52 wk Range
239.51
338.89
CI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cigna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
279.67284.24
52 wk Range
239.51338.89
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cigna's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
341.75
Upside
+21.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 5 consecutive years
- Cigna Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cigna Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Cigna Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cigna Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cigna Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
21 Buy
3 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 341.75
(+21.63% Upside)
Cigna Corp SWOT Analysis
PBM Innovation | Cigna's new Pharmacy Benefit Management model strategically positions the company to mitigate regulatory risks while creating competitive differentiation in the healthcare market. |
Financial Resilience | With EPS estimates of $29.60 for FY1 and ranging between $30.70-$33.75 for FY2, Cigna maintains a robust 10-14% long-term growth trajectory supported by a $7.7 billion buyback program. |
Analyst Confidence | Explore the bullish outlook from major firms, with price targets averaging $358—ranging from $300 to $383—and predominantly "Overweight" ratings signaling strong growth potential. |
Market Positioning | Delve into Cigna's strategic gains in the $300 billion Select employer segment and its specialty pharmacy innovations, balanced against regulatory uncertainties and competitive pressures. |
Cigna Corp Earnings Call Summary for Q1/2026
- Cigna Q1 2026 EPS of $7.79 beat forecast by 2.37%; revenue hit $68.5B, exceeding expectations by 3.5%
- Full-year 2026 EPS guidance raised to at least $30.35; Q2 expected to represent approximately 25% of annual outlook
- Stock declined 3.22% to $282.90 in pre-market despite earnings beat; debt-to-capitalization ratio improved to 42.3%
- Evernorth Health Services drove growth through specialty drugs and biosimilars; Signature rebate-free pharmacy model gaining traction
- Leadership transition underway with Brian Evanko as incoming CEO, emphasizing AI integration and consumer-focused health services
Last Updated: 09/05/2026, 07:48
Read Full TranscriptEarnings
Latest Release
Apr 30, 2026
EPS / Forecast
7.79 / 7.61
Revenue / Forecast
68.52B / 66.2B
Compare CI to Peers and Sector
Metrics to compare | CI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.8x | 14.4x | −0.5x | |
PEG Ratio | 0.38 | 0.39 | 0.00 | |
Price/Book | 1.8x | 1.9x | 2.6x | |
Price / LTM Sales | 0.3x | 1.5x | 3.1x | |
Upside (Analyst Target) | 20.8% | 16.1% | 52.5% | |
Fair Value Upside | Unlock | 12.9% | 6.0% | Unlock |
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cigna (CI) Stock Price Today?
The Cigna stock price today is 280.97 USD.
What Stock Exchange Does Cigna Trade On?
Cigna is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Cigna?
The stock symbol for Cigna is "CI."
What Is the Cigna (CI) Afterhours Price Today? (Afterhours variable test: 281.86) Current Date: May 26, 2026
After hours price: 281.86. After hours price change (units): 1.03. Price change percentage: 0.37%
What Is the Cigna Market Cap?
As of today, Cigna market cap is 74.26B USD.
What Is Cigna's Earnings Per Share (TTM)?
The Cigna EPS (TTM) is 23.60.
When Is the Next Cigna Earnings Date?
Cigna will release its next earnings report on Jul 30, 2026.
From a Technical Analysis Perspective, Is CI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Cigna Stock Split?
Cigna has split 2 times.
How Many Employees Does Cigna Have?
Cigna has 66685 employees.
What is the current trading status of Cigna (CI)?
As of May 26, 2026, Cigna (CI) is trading at a price of 280.97 USD, with a previous close of 286.24 USD. The stock has fluctuated within a day range of 279.67 USD to 284.24 USD, while its 52-week range spans from 239.51 USD to 338.89 USD.
What Is Cigna (CI) Price Target According to Analysts?
The average 12-month price target for Cigna is 341.75 USD, with a high estimate of 400 USD and a low estimate of 290 USD. 21 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +21.63% Upside potential.
What Is the CI Premarket Price?
CI's last pre-market stock price is 284.90 USD. The pre-market share volume is 1,710.00, and the stock has decreased by -1.34, or -0.47%.
What Is the CI After Hours Price?
CI's last after hours stock price is 281.86 USD, the stock has decreased by 1.03, or 0.37%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.